The changing pattern of non-small cell lung cancer between the 90th and 2000th decades

Open Respiratory Medicine Journal

Volumn 5, Issue 1, 2011, Pages 24-30

  Montesinos, Jesus ^a   Bare, Marisa ^b   Dalmau, Elsa ^b   Saigi, Eugeni ^b   Villace, Pablo ^b   Nogue, Miquel ^c   Segui, Miquel Angel ^b   Arnau, Anna ^a   Bonfill, Xavier ^d  

^a Althaia   (Spain)

^b Servicio de Cirugía General Y Aparato Digestivo   (Spain)

^c HOSPITAL GENERAL DE VIC   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Carcinoma; Mortality; Multivariate analysis; Non small cell lung; Registries

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUALITY OF LIFE; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT PLANNING; TUMOR CLASSIFICATION;

EID: 80053549507     PISSN: None     EISSN: 18743064     Source Type: Journal    
DOI: 10.2174/1874306401105010024     Document Type: Article

References (22)

1. Karim-Kos HE, de VE, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44: 1345-89.
2. Verdecchia A, Guzzinati S, Francisci S, et al. Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 2009; 45: 1042-66.
3. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-92.
4. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481-8.
5. Sant M, Aareleid T, Berrino F, et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 2003; 14(Suppl 5): v61-118.
6. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009; 45: 931-91.
7. Estrategia en cancer del sistema nacional de salud. Ministerio de Sanidad y Consumo 2006. Online source. Avalaible at http://www.msc.es/organizacion/sns/planCalidadSNS/pdf/excelencia/cancer-cardiopatia/CANCER/opsc_est1.pdf [Last accessed 15 september 2010]
8. López-Abente G, Pollán M, Aragonés N, et al. Situación del cáncer en España: incidencia. 2004. Online source. Available at http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137-66272004000300001&lng=es [Last accessed 15 september 2010]
9. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995; 311: 899-909.
10. Janssen-Heijnen ML, Gatta G, Forman D, Capocaccia R, Coebergh JW. Variation in survival of patients with lung cancer in Europe, 1985-1989. Eur J Cancer 1998; 34: 2191-6.
11. Ruiz A, Facio A. Hospital-based cancer registry: a tool for patient care, management and quality:a focus on its use for quality assessment. Clin Transl Oncol 2004; 6(2): 104-13.
12. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111: 1710-7.
13. National Cancer Institute. Bethesda M. SEER Cancer Statistics Review, 1975-2006. 2009. Online source. Avalaible at http://seer.cancer.gov/csr/1975_2006/ [Last accessed 15 september 2010]
14. Tsukuma H, Ajiki W, Ioka A, Oshima A. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol 2006; 36: 602-7.
15. Micheli A, Ciampichini R, Oberaigner W, et al. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 2009; 45: 1017-27.
16. Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male: female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005; 117: 294-9.
17. Hatcher J, Dover DC. Trends in histopathology of lung cancer in Alberta. Can J Public Health 2003; 94: 292-6.
18. Shepherd FA, Dancey J, Ramlau R, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with nonsmall-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 2000; 18: 2095-103.
19. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005; 353: 123-32.
20. Petrelli NJ, Winer EP, Brahmer J, et al. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening-a report from the American Society of Clinical Oncology. J Clin Oncol 2009; 27: 6052-69.
21. Lung cancer survival statistics UK. 2007. Online source. Avalaible at http://info.cancerresearchuk.org/cancerstats/types/lung/survival/ [Last accessed 15 september 2010]
22. De Angelis R, Francisci S, Baili P, et al. The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis. Eur J Cancer 2009; 45: 909-30.